Stephen Davis, CEO: Acadia Pharmaceuticals ACAD Sell · Filed 24/05/03

Trade details

Type: Insider sale
Amount: $193,573.38
Shares · price: 11,427 sh · $16.94 a share
Held after: 155,231 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Stephen DavisCEO
Trade date: 24/05/02
Filed: 24/05/03
Days to filing: 1 days

Sold 6.9% of holdings

Share of holding sold: 6.9%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/02~24/06/01

Stephen Davis's recent trades

Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$485.1K
31,747 sh
$485.1K
Filed 24/08/20
Traded 24/08/19
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$316.6K
17,716 sh
$316.6K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$158.3K
8,858 sh
$158.3K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$317.1K
17,714 sh
$317.1K
Filed 24/03/27
Traded 24/03/27
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$137.6K
5,577 sh
$137.6K
Filed 24/02/27
Traded 24/02/26

Stephen Davis, CEO — sold $193.6K of Acadia Pharmaceuticals ACAD · 6.9% of holdings | Whalegun